Trump expands voluntary drug-price deals with nine more manufacturers
TL;DR Summary
President Trump announced a new round of voluntary drug-pricing agreements with nine manufacturers, bringing the total to 26 deals since the program began. The pledges include pricing drugs near the lowest international rates, applying most-favored-nation terms to Medicaid, and, in some cases, boosting domestic manufacturing and stockpiles. Details are not publicly released, and the overall impact on costs remains unclear.
Topics:nation#drug-pricing#healthcare-policy#medicaid#pharmaceutical-industry#politics#trump-administration
- Trump strikes nine more deals with drugmakers to lower prices STAT
- Bond yields climb; CSL to lower prices in Trump deal; AI was meant to kill software, so what happened? AFR
- CSL discounts drugs in US after Trump tariff threats The West Australian
- Trump announces new drug-pricing deals with 9 pharma companies NBC News
- Trump strikes new drug pricing deals with nine midsized drugmakers CNBC
Reading Insights
Total Reads
0
Unique Readers
6
Time Saved
4 min
vs 4 min read
Condensed
92%
776 → 60 words
Want the full story? Read the original article
Read on STAT